SLAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. Price action is weak (down ~3.15% today and below the pivot), MACD is bearish and worsening, and hedge funds are aggressively selling. Despite bullish options positioning, there’s no proprietary buy signal and no near-term catalyst support from news. Best stance is hold/avoid new buys until SLAB reclaims ~147 (pivot) and shows momentum stabilization.
Trend/momentum is currently bearish-to-neutral. MACD histogram is -0.94 and negatively expanding, signaling strengthening downside momentum. RSI(6) ~42.95 is neutral but leaning weak (not oversold, so downside can continue). Moving averages are converging, implying indecision but not a confirmed uptrend. Key levels: Support S1 ~139.67 (price 141.89 is close—risk of a break), then S2 ~135.12. Resistance/pivot ~147.02 is the first level bulls need to regain; above that, R1 ~154.37. Near-term pattern stats suggest only modest upside (next day +0.95% probability/expected move) and slightly negative bias over the next week (-0.37%).
Options market is notably bullish (very low put/call ratios; elevated volume).
Revenue growth is strong YoY (+23.8% in 2025/Q
and gross margin improved (+6.45% YoY to 57.78%), indicating better product mix/pricing.
Upcoming earnings (2026-02-10 pre-market) with EPS estimate around +0.03 could act as a catalyst if profitability inflects upward.
Technical momentum is weakening (bearish, expanding MACD) while price sits close to key support (~139.7), increasing near-term breakdown risk.
Hedge funds are selling aggressively (selling amount up ~356.79% QoQ), a meaningful sentiment/flow headwind.
Profitability deteriorated in the latest quarter (net income -$9.94M; EPS -0.30), so the market may continue to punish the stock until earnings clearly turn.
No supportive recent news flow in the past week to reverse the current tape.
Latest reported quarter: 2025/Q3. Revenue rose to ~$206.0M (+23.80% YoY), and gross margin improved to 57.78% (+6.45% YoY), which is constructive on operating quality. However, net income fell to about -$9.94M (down -65.14% YoY) and EPS declined to -0.30 (down -65.91% YoY), showing that despite higher sales and better margin, bottom-line performance is still negative—this weakens the near-term investment case.
No analyst rating or price target change data was provided, so a recent trend summary can’t be confirmed from the dataset. Based on available inputs only, the closest proxy to 'Street/Pro' positioning is mixed-to-negative: hedge fund flow is sharply negative, while options positioning is bullish. Net: pros are not aligned—flows suggest caution even as options traders lean bullish.
